Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NB Private Equity Partners Ltd | 31X | Sep 27, 2024 | 19.00 | +0.53 |
NCAB GROUP AB | XB1 | Sep 27, 2024 | 5.79 | -0.94 |
NCC B | NCGB | Sep 27, 2024 | 14.93 | +1.63 |
NCC Group | NZB | Sep 27, 2024 | 2.08 | +2.97 |
NCI | NCL | Sep 27, 2024 | 2.28 | +2.70 |
Ncino | 6NCA | Sep 27, 2024 | 27.60 | +2.22 |
NCR Corporation | NCR1 | Sep 27, 2024 | 11.70 | +0.86 |
NCS Multistage Holdings, Inc. | MUH0 | Sep 27, 2024 | 17.10 | +0.59 |
ND PAPER | N3Y | Sep 27, 2024 | 0.39 | +9.50 |
NE ELECTRIC | NE4H | Sep 27, 2024 | 0.01 | -4.17 |
NEC Corporation | NEC1 | Sep 27, 2024 | 85.00 | -2.83 |
Nedap (Nederlandsche Apparatenf) NV | NE3 | Sep 27, 2024 | 56.80 | +2.16 |
Nedbank Group Ltd. | NCO | Sep 27, 2024 | 15.90 | +1.92 |
NEDERMAN HLDG AB | 5QR | Sep 27, 2024 | 19.64 | +1.13 |
Neinor Homes | 1NN | Sep 27, 2024 | 14.78 | +0.68 |
Nekkar | 0TT | Sep 27, 2024 | 0.73 | -11.78 |
Nektar Therapeutics | ITH | Sep 27, 2024 | 0.99 | -3.37 |
NEL | D7G | Sep 27, 2024 | 0.42 | +1.39 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Sep 27, 2024 | 11.60 | -1.69 |
Nelly Group | CD20 | Sep 27, 2024 | 2.19 | -0.91 |
Nelnet, Inc. | NIJ | Sep 27, 2024 | 99.50 | +1.02 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Sep 27, 2024 | 17.80 | +2.89 |
Nemetschek SE | NEM | Sep 27, 2024 | 93.25 | -1.53 |
NENT Group B | NEB | Sep 27, 2024 | 0.07 | +1.08 |
Neo Performance Materials Inc | N14 | Sep 27, 2024 | 5.36 | +2.49 |
NEO-NEON | N2L | Sep 27, 2024 | 0.03 | -1.72 |
Neodecortech S.p.a. | FM2 | Sep 27, 2024 | 3.05 | 0.00 |
Neoen S.A. | N1N | Sep 27, 2024 | 38.48 | -0.52 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Sep 27, 2024 | 10.90 | 0.00 |
Neogen Corporation | NG2 | Sep 27, 2024 | 14.80 | +0.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.